Before the validation of the lysoSM509, the NPC Brazil Network was analyzing solely the levels of Chitotriosidase activity, performing molecular analysis of the NPC1 and NPC2 genes in the samples with increased Chitotriosidase activity. The gene discussed is CHIT1; the disease is nasopharyngeal carcinoma.